Prevention of Shingles: Better Protection and Better Value With Recombinant Vaccine

Ann Intern Med. 2019 Mar 19;170(6):416-417. doi: 10.7326/M19-0141. Epub 2019 Feb 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Herpes Zoster*
  • Herpesvirus 3, Human
  • Humans
  • Vaccination
  • Vaccines, Synthetic

Substances

  • Vaccines, Synthetic